We Work for Health | Washington

09/10/2025

"Few industries are more vital to our national security than the biomedical sector. And yet, for far too long, we’ve ceded ground to foreign suppliers."

Don't let give other countries a competitive advantage: https://www.washingtonexaminer.com/restoring-america/courage-strength-optimism/3793335/china-medicine-supply-chains-national-security/

09/08/2025

"It is possible that even triple-digit tariffs would not compel companies to shift production of these drugs to the United States in the near future, and even if they did, short-term shortages are still likely."

https://www.realclearhealth.com/articles/2025/09/05/steep_drug_tariffs_could_lead_to_short-term_shortages_1133110.html

09/05/2025

" – socialism in disguise – would only undermine incentives for high-risk, high-cost drug development. A more effective approach would follow President Trump’s extremely successful NATO model, pushing other wealthy nations to pay their fair share."

https://www.realclearhealth.com/articles/2025/08/28/the_path_to_lower_seniors_drug_costs_without_embracing_foreign_price_controls_1131675.html

09/03/2025

"Because most European countries impose strict price controls on pharmaceuticals, manufacturers generate lower revenue per patient, leaving less funds to bring future drugs to market."

doesn't support U.S. research and development:

Trump is correct to seek to lower drug prices, but price controls will leave Americans with less choices without addressing the problem.

08/29/2025

"Medicare and Medicaid “should refrain from pursuing” policies “that attempt to model US [drug] pricing after the pricing in other countries, which may heavily rely on QALYs and often deny people with disabilities access to needed care.”"

https://www.wsj.com/opinion/trumps-drug-price-plan-would-hurt-the-disabled-52ebc16f

08/27/2025

Bristol Myers Squibb hosted a fantastic facilities tour for the WWFH WA team today!

A very special thank you to members of Representative Rick Larsen, Congresswoman Suzan DelBene and Congresswoman Marilyn Strickland's offices for joining us, and to Life Science Washington and the NW Rare Disease Coalition for your advocacy efforts.

08/27/2025

Listen in: https://www.youtube.com/watch?v=T1FjEuKZMgY

Dr. Ned Sharpless, former NCI Director, Acting FDA Commissioner, and venture capitalist at Jupiter Bio Ventures, discusses the challenges of funding, regulatory uncertainty, the and the rise of China in biotech.

This week, John Stanford sits down with Dr. Ned Sharpless - former NCI Director, Acting FDA Commissioner, and now venture capitalist at Jupiter Bio Ventures....

08/27/2025

"Americans seek health system reforms that are guided by and deliver what matters most to : timely access to affordable care, support in managing chronic conditions, access to new treatments, and the ability to make informed choices."

https://nationalhealthcouncil.org/letters-comments/nhc-statement-patients-as-partners-in-drug-pricing-and-health-system-reforms/

08/22/2025

"Undermining IP rights in the name of short-term cost savings sends a dangerous message across the entire innovation economy -- from energy and defense technology to artificial intelligence."

policy flies in the face of U.S. innovation efforts: https://www.realclearhealth.com/articles/2025/08/15/dont_import_foreign_price_controls_1129128.html

08/20/2025

"Negotiating trade agreements and cracking down on ' and hospitals' abuse of patients would lead to real savings for patients -- without sacrificing innovation."

Close loopholes in existing policies instead of moving forward with :

President Trump recently set an ambitious goal -- ensure that Americans pay lower prices for medicines than patients in any other developed country. He's rightly frustrated that ot

08/18/2025

"Over time, all American patients, including veterans, could come to rely on state-backed Chinese firms for cutting-edge treatments and essential medicines.

That would pose an unacceptable threat to our national security."

weakens U.S. competition: https://thehill.com/opinion/healthcare/5450489-veterans-health-trump-drug-prices/

08/15/2025

“Ultimately, a shared goal is for American patients to benefit from a health care system that continually produces new lifesaving treatments alongside the competition that ultimately makes them cheaper”

isn't the solution: https://mostfavoredpatient.org/